» Articles » PMID: 15050644

(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a Potent and Efficacious KCNQ2 Opener Which Inhibits Induced Hyperexcitability of Rat Hippocampal Neurons

Abstract

(S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide ((S)-2) was identified as a potent and efficacious KCNQ2 opener. This compound demonstrated significant activity in reducing neuronal hyperexcitability in rat hippocampal slices, and the inhibition mediated by (S)-2 was reversed by the KCNQ blocker linopirdine.

Citing Articles

Chemical modulation of Kv7 potassium channels.

Borgini M, Mondal P, Liu R, Wipf P RSC Med Chem. 2021; 12(4):483-537.

PMID: 34046626 PMC: 8128042. DOI: 10.1039/d0md00328j.


Pharmacological Activation of Neuronal Voltage-Gated Kv7/KCNQ/M-Channels for Potential Therapy of Epilepsy and Pain.

Liu Y, Bian X, Wang K Handb Exp Pharmacol. 2021; 267:231-251.

PMID: 33837465 DOI: 10.1007/164_2021_458.


M-type K channels in peripheral nociceptive pathways.

Du X, Gao H, Jaffe D, Zhang H, Gamper N Br J Pharmacol. 2017; 175(12):2158-2172.

PMID: 28800673 PMC: 5980636. DOI: 10.1111/bph.13978.


From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group.

Blom S, Rottlander M, Kehler J, Bundgaard C, Schmitt N, Jensen H PLoS One. 2014; 9(6):e100209.

PMID: 24956197 PMC: 4067310. DOI: 10.1371/journal.pone.0100209.


Potassium channels in peripheral pain pathways: expression, function and therapeutic potential.

Du X, Gamper N Curr Neuropharmacol. 2014; 11(6):621-40.

PMID: 24396338 PMC: 3849788. DOI: 10.2174/1570159X113119990042.